Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CYSLTR1 Biologics Sequence Review Report 2026: Cysteinyl leukotriene receptor 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CYSLTR1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CXADR Biologics Sequence Review Report 2026: Coxsackievirus and adenovirus receptor Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CXADR sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CTAG2 Biologics Sequence Review Report 2026: Cancer/testis antigen 2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CTAG2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CTAG1A Biologics Sequence Review Report 2026: Cancer/testis antigen 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CTAG1A sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CT55 Biologics Sequence Review Report 2026: Cancer/testis antigen 55 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CT55 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CT45A1 Biologics Sequence Review Report 2026: Cancer/testis antigen family 45 member A1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CT45A1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CRHR2 Biologics Sequence Review Report 2026: Corticotropin-releasing hormone receptor 2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CRHR2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CR1 Biologics Sequence Review Report 2026: Complement receptor type 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CR1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CMKLR1 Biologics Sequence Review Report 2026: Chemerin-like receptor 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CMKLR1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CLNK Biologics Sequence Review Report 2026: Cytokine-dependent hematopoietic cell linker Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CLNK sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CLCF1 Biologics Sequence Review Report 2026: Cardiotrophin-like cytokine factor 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CLCF1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CKLF Biologics Sequence Review Report 2026: Chemokine-like factor Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CKLF sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
220
221
222
223
224
>>
2260
>